- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04435171
Comparison of Postoperative Early Period Quality of Life of Patients With Open and Robot Assisted Kidney Transplantation
June 17, 2020 updated by: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Comparison of Postoperative Early Period Quality of Life of Patients With Open and Robot Assisted Kidney Transplantation: a Prospective Observational Study
The investigators aimed to investigate the quality of life in patients with end-stage renal disease who underwent open or robot-assisted renal transplantation.
Also, the investigators sought to determine the parameters which can affect the quality of life in these patients
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients who underwent open or robot-assisted renal transplantation at Bakirkoy Sadi Konuk Training and Research Hospital between June 2016 and December 2018 constituted the target population of this study.
After application of the inclusion and exclusion criteria, the patient group was divided into two groups as per the surgical technique (i.e., open vs. robot-assisted).
Demographic data, preoperative and postoperative data of all patients were collected prospectively.
The quality of life of the patients was assessed preoperatively and on the postoperative 30th day
Study Type
Observational
Enrollment (Actual)
129
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey, 34275
- Bakirkoy Dr Sadi Konuk Training and Research Hospital, Department of Urology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who were performed open or robot assisted renal transplantation due to End Stage Renal Disease
Description
Inclusion Criteria:
- Patients aged between 18 and 75
- Who were diagnosed with End Stage Renal Disease (i.e., estimated glomerular filtration rate loer than 20 ml/minute or symptomatic uremia or dialysis requirement)
- Received a kidney from a live donor
Exclusion Criteria:
- Patients with mental retardation, dementia, and psychotic or cognitive disorders, including delirium
- Patients who underwent deceased renal transplantation and who underwent simple bilateral nephrectomy or any other surgical procedure concurrent with Open renal transplantation
- Patients who died or had graft failure during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Open renal transplantation
Patients who were performed open renal transplantation due to end stage renal disease.
|
Open or robot assisted renal transplantation
|
robot assisted renal transplantation
Patients who were performed robot assisted renal transplantation due to end stage renal disease
|
Open or robot assisted renal transplantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of change for Quality of Life (measure : Short Form 36) after open and robot assisted renal transplantation
Time Frame: From just before the treatment and up to 30 days after the surgery was performed
|
Percentage of change for quality of life (measure : Short Form 36) for patients who performed open and robot assisted renal transplantation due to end stage renal disease.
Scores of the Short Form-36 Health Survey vary between 0 and 100, a score of 0 corresponds to the lowest quality, while 100 indicates the highest quality.
|
From just before the treatment and up to 30 days after the surgery was performed
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mithat Ekşi, Bakırköy Dr. Sadi Konuk Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2016
Primary Completion (Actual)
December 15, 2018
Study Completion (Actual)
May 20, 2020
Study Registration Dates
First Submitted
May 22, 2020
First Submitted That Met QC Criteria
June 15, 2020
First Posted (Actual)
June 17, 2020
Study Record Updates
Last Update Posted (Actual)
June 19, 2020
Last Update Submitted That Met QC Criteria
June 17, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- Renal Transplantation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on Renal transplantation
-
Ankara City Hospital BilkentNot yet recruitingHypotension | Renal Transplant Failure and RejectionTurkey
-
Centre Hospitalier Universitaire VaudoisCompletedObstructive Sleep Apnea | End Stage Renal Disease | Renal Transplantation | OverhydrationSwitzerland
-
University Hospital, MontpellierTerminatedChronic Renal Failure Requiring HemodialysisFrance
-
Patrick SchjelderupAarhus University HospitalNot yet recruitingKidney Transplantation | Living Donors | Senescence | Renal Fibrosis | Multiparametric Magnetic Resonance Imaging
-
Mayo ClinicRecruitingChronic Kidney Diseases | Transplant | Neurogenic Bladder | Bladder Outlet Obstruction | Bladder Dysfunction | Bladder Exstrophy | Bladder Absence | Posterior Urethral Valve | Failure, KidneyUnited States
-
Hospices Civils de LyonUnknown
-
Wake Forest University Health SciencesStanford UniversityCompletedRenal Transplant | Rejection Acute Renal | Rejection Chronic Renal | Rejection of Renal Transplant | Renin-Angiotensin SystemUnited States
-
University of GiessenNovartis; Astellas Pharma US, Inc.; German Cancer Research Center; Heidelberg UniversityCompletedKidney Transplantation | Immunology | Virus | Living Donors | Rituximab (RTx)Germany
-
Medtronic VascularCompletedCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
Hainv GaoActive, not recruitingHepatic EncephalopathyChina